The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Frigo N.V.

Moscow Sientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia, 119071

Michenko A.V.

Pervyĭ MGMU im. I.M. Sechenova

Lvov A.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Panteleev A.A.

National Research Center «Kurchatov Institute», Moscow, Russia

Kitaeva N.V.

Moscow Scientic and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Chronic indolent ulcers and wounds of the skin and subcutaneous tissue (in Russian only)

Authors:

Potekaev N.N., Frigo N.V., Michenko A.V., Lvov A.N., Panteleev A.A., Kitaeva N.V.

More about the authors

Read: 16529 times


To cite this article:

Potekaev NN, Frigo NV, Michenko AV, Lvov AN, Panteleev AA, Kitaeva NV. Chronic indolent ulcers and wounds of the skin and subcutaneous tissue (in Russian only). Russian Journal of Clinical Dermatology and Venereology. 2018;17(6):7‑12. (In Russ.)
https://doi.org/10.17116/klinderma2018170617

Recommended articles:
Epidemiology of M. geni­talium infe­ction. What is known?. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):143-152
Bacterial vagi­nosis: modern views. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):261-268
Study of the role of inte­rleukin-1β in blood serum in patients with acne. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):421-424
Pathogenesis of fibrosis deve­lopment in ovarian endo­metriosis. Russian Journal of Archive of Pathology. 2025;(2):73-78
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Portopulmonary hype­rtension. Journal of Respiratory Medi­cine. 2025;(2):39-44

References:

  1. Tolstykh P, Tamrazova O, Pavlenko V, et al. Long-lasting non-healing wounds and ulcers. Pathogenesis, clinic, treatment. M. 2009. (In Russ.)
  2. Stone RC, et al. A bioengineered living cell construct activates an acute wound healing response in venous leg ulcers. Sci Transl Med. 2017 Jan 4; 9(371);pii: eaaf8611
  3. Rice JB, Desai U, Cummings AK, et al. Burden of venous leg ulcers in the United States. J Med Econ. 2014;17:347-356.
  4. Driscoll P. Wound prevalence and wound management, 2012–2020. 2013. Accessed on 14 September 2015. Available online: http://blog.mediligence.com/2013/01/29/wound-prevalence-and-wound-management-2012-2020/
  5. Obolensky VN, Rodoman GV, Nikitin VG, Karev MA. Trophic ulcers of the lower extremities — a review of the problem. RMZh. 2009;17:25(364):1647-1662. (In Russ.)
  6. Shanmugam VK, Angra D, Rahimi H, McNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord. 2017 Mar;5(2):280-292.
  7. Lam G, et al. Nonhealing ulcers in patients with tophaceous gout: a systematic review. Adv Skin Wound Care. 2017 May;30(5):230-237.
  8. Arase N, et al. Novel autoantibody against the β2-glycoprotein I/HLA-DR complex in patients with refractory cutaneous ulcers. Br J Dermatol. 2017 Apr 12. https://doi.org/10.1111/bjd.15571
  9. Mustoe T. Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004;187:S65-S70.
  10. Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J Am Acad Dermatol. 2008;58:185-206.
  11. Savelyev VS, Kirienko AI, Bogachev VYu. Venous trophic ulcers. Myths and realities. Phlebolymphed. 2000;11:5-10. (In Russ.)
  12. Jones J, Barr W, Robinson J, Carlisle C. Depression in patients with chronic venous ulceration. Br J Nurs. 2006;15(11):S17-S23.
  13. Sasanka CS. Venous ulcers of the lower limb: where do we stand? Indian J Plast Surg. 2012;45(2):266-274.
  14. Bonham PA. Assessment and management of patients with venous, arterial, and diabetic/neuropathic lower extremity wounds. AACN Clin Issues. 2003;14:442-456.
  15. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-1340.
  16. Dedov II, et al. Screening of complications of diabetes mellitus as a method of evaluation of medical-prophylactic treatment of patients. Diabetes mellitus. 2006;4:38-42. (In Russ.)
  17. Brehovsky VB. The experience of applying dressings on the basis of the water-solubility of colloidal technology in the outpatient treatment of venous ulcers stop Endocrine surg. 2011;1:29-33. (In Russ.)
  18. Dedov II, Suntsov YuI, Kudryakova SV. Economic problems of diabetes mellitus in Russia. Diabetes mellitus. 2000;3:56-58. (In Russ.)
  19. Matricali GA, et al. Economic aspects of diabetic foot care in multidisciplinary setting. Diabetes and Metabolism. Research and Reviews. 2007;23:337-348.
  20. Dedov II, Udovichenko OV, Galstyan GR. Diabetic foot. Practical meditsine. 2005;197. (In Russ.)
  21. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team. J Vasc Surg. 2010;52:17S-22S.
  22. Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu Z. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28 Suppl 1:107-111.
  23. Ramachandran A, Ramachandran S, Snehalata C, et al. Increasing expenditure on health care incurred by diabetic subjects in a developing country. Diabetes Care. 2007;30:252-256.
  24. Gur’eva IV. Risk factors for diabetic foot syndrome. Rus med J. 2003;6:338-342. (In Russ.)
  25. Bergstrom N. Pressure ulcers in adults: prediction and prevention. Clinical Practice Guideline, Number 3. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. 1992. May. AHCPR Publication No 92-0047; avaiiable at: http://ilive.com.ua/health/prolezhni_108562i15941.html
  26. Tamrazova OB. Long-term non-healing ulcers of the lower extremities: pathogenetic justification of the tactics of therapy choice: Dis. of Dr. Med. Sciences. M. 2013. (In Russ.).
  27. Khramilin VN. Modern aspects of topical treatment of chronic wounds of the lower extremities in diabetic patients. Scientific-practical medical journal of endocrinological research centre of Russian Academy of medical Sciences. 2005;4:26-30. (In Russ.).
  28. Catrina SB, Zheng X. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:179-185.
  29. Thomas DR, Compton GA. Pressure Ulcers in the Aging Population. A Guide for Clinicians. Humana Press. 2014:233.
  30. Schultz GS, Mast BA. Molecular analysis of the environment of healing and chronic wounds: Cytokines, proteases, and growth factors. Wounds Compend Clin Res Pract. 1998;10:1f-9f.
  31. Mast BA, Schultz GS. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996;4:411-420.
  32. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS. Biofilms in chronic wounds. Wound Repair Regen. 2008;16:37-44.
  33. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care. 2008;17:333-341.
  34. Apelqvist J, et al. EWMA Document: Negative Pressure Wound Therapy. J Wound Care. 2017 Mar 1;26(Sup3):S1-S154.
  35. Maruccia M, et al. An Alternative Treatment Strategy for Complicated Chronic Wounds: Negative Pressure Therapy over Mesh Skin Graft. Biomed Res Int. 2017;2017:8395219
  36. Sergeev NA, Shestakov MS. Treatment of trophic ulcers of the lower extremity venous etiology with application of low-intensity laser radiation. Russian medical journal. 2013;5:36-38. (In Russ.)
  37. Prosyannikova NV, Lipova EV, Pokrovsky KA, Tarasenko GN. Platelet concentrate in chronic ulcerative skin defects. Rus j skin vener dis. 2013;2:20-23. (In Russ.).
  38. Bogdan VG, Tolstov DA. Prospective randomized clinical study of the effectiveness of autologous platelet concentrates for stimulation of trophic ulcers regeneration in venous etiology. Surgery news 2014;22:3:344-350. (In Russ.)
  39. Zhukova OV, Kruglova LS, et al. Combined ultrasonic therapy and literatures in the treatment of patients with trophic ulcers of venous Genesis. J new med technol (electronic journal) 2014;2:84. (In Russ.).
  40. Kruglova LS, et al. To the question of treatment of trophic ulcers of venous Genesis. The act quest dermatovenereol dermatooncol. 2014;43-45. (In Russ.)
  41. Aspiroz C, et al. Photodynamic therapy with methylene blue worth considering for skin ulcers infected with Pseudomonas aeruginosa and Fusarium spp. Actas Dermosifiliogr. 2017 Apr 12;pii: S0001-7310(17)30077-7.
  42. Lam G, et al. Hyperbaric oxygen therapy: exploring the clinical evidence. Adv Skin Wound Care. 2017 Apr;30(4):181-190.
  43. Lohmann N, et al. Glycosaminoglycan-based hydrogels capture inflammatory chemokines and rescue defective wound healing in mice. Sci Transl Med. 2017 Apr 19;9(386);pii: eaai9044.
  44. Yoon DS, et al. Cell recruiting chemokine-loaded sprayable gelatin hydrogel dressings for diabetic wound healing. Acta Biomater. 2016 Jul 1;38:59-68.
  45. Masters KS, et al. Effects of nitric oxide releasing poly(vinyl alcohol) hydrogel dressings on dermal wound healing in diabetic mice. Wound Repair Regen. 2002 Sep-Oct;10(5):286-294.
  46. Wu J, et al. Comparative Study of Heparin-Poloxamer Hydrogel Modified βFGF and αFGF for in Vivo Wound Healing Efficiency. ACS Appl Mater Interfaces. 2016 Jul 27;8(29):18710-18721.
  47. Stefanov I, et al. Multifunctional enzymatically-generated hydrogels for chronic wound application. Biomacromolecules. 2017 Apr 19. [Epub ahead of print] https://doi.org/10.1021/acs.biomac.7b00111
  48. Bartolucci P, et al. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford). 2002 Oct;41(10):1126-1132.
  49. Jiang XY, et al. Progress in stem cell therapy for the diabetic foot. Diabetes Res Clin Pract. 2012 Jul;97(1):43-50.
  50. Jiang X, Zhang H, Teng M. Effectiveness of Autologous Stem Cell Therapy for the Treatment of Lower Extremity Ulcers: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2016 Mar;95(11):e2716.
  51. Grada A, Falanga V. Novel Stem Cell Therapies for Applications to Wound Healing and Tissue Repair. Surg Technol Int. 2016 Oct 26;29:29-37.
  52. Acosta JB, Savigne W, Valdez C, et al. Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds. Int Wound J. 2006;3(3):232-239.
  53. Galstyan GR, Ignatieva IV, Avksent’eva MV, Dedov II. Clinical and economic analysis of the drug epidermal growth factor (Heberprot) in patients with diabetic foot syndrome Endocrine sur. 2013;1 4-16. (In Russ.)
  54. Zhao R, et al. Inflammation in Chronic Wounds. Int J Mol Sci. 2016 Dec 11;17(12);pii: E2085.
  55. Hershcovitch MD, Hom DB. Update in wound healing in facial plastic surgery. Arch Facial Plast Surg. 2012;14:387-393.
  56. Rodgers KE, Bolton LL, Verco S, di Zerega GS. NorLeu-angiotensin (1—7) [DSC127] as a therapy for the healing of diabetic foot ulcers. Adv Wound Care. 2015;4:339-345.
  57. Sogabe Y, et al. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation. Wound Repair Regen. 2006;14:457-462.
  58. Robson MC, et al. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann Surg. 1992;216:401-406.
  59. Richard JL, et al. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care. 1995;18:64-69.
  60. Uchi H, et al. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol. 2009;19:461-468.
  61. Kusumanto YH, et al.Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther. 2006;17:683-691.
  62. Saaristo A, et al. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol. 2006;169:1080-1087.
  63. Genentech Announces Full Year and Fourth Quarter 2007 Results. 2008. Accessed on 30 November 2016. Available online: https://www.gene.com/media/press-releases/10967/2008-01-14/genentech-announces-full-year-and-fourth
  64. Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: Mechanisms, signaling, and translation. Sci Transl Med. 2014;6.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.